Main Industry
Biotechnology
Main Product/Service
1. AC-203
2. AC-1101
3. AC-203
2. AC-1101
3. AC-203
The content above was translated by Ai
Founded Year
2010
Unified Business No.
25147136
Status
Active
Number of Employees
0
Total Paid-in
Capital
2,235,793,950 (NT$)
Location of Company
Taiwan
, Taipei City
Exit Status
Emerging Stock Exchange(2016)
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Ancheng Biotechnology Co., Ltd. (hereinafter referred to as Ancheng Biotech) is a new drug research and development company headquartered in Taipei, Taiwan, which develops and treats rare diseases. The strategy is to re-position the drug molecules already in clinical use. There is no need for good medicine or emerging medicines, especially for rarediseases that are severely and drug-free. They aim to be efficient and innovative, providing safe and effective new drugs to patients in need around the world.
The content above was translated by Ai
